Financials
- Market Capitalization 3.9 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.24
Rapporto prezzo/fatturato
10.36
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1522 | VKTX Viking Therapeutics, Inc. - Common Stock | 33.86 USD | -1.51% | -2.67% | +0.03% | +22.42% | 3.95 B USD | ||
| 1523 | DNLI Denali Therapeutics Inc. - Common Stock | 24.67 USD | +0.41% | -2.26% | +3.31% | +52.57% | 3.94 B USD | ||
| 1545 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.38 USD | +2.25% | +0.35% | +10.70% | +80.35% | 3.86 B USD | ||
| 1557 | ABCL AbCellera Biologics Inc. - Common Shares | 11.91 USD | -3.95% | +3.93% | +121.38% | +176.98% | 3.65 B USD |